- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Migalastat – March 2017
Migalastat: Capsule 150 mg; Galafold®
Last updated
20 September 2017